- ReWalK press release ( NASDAQ: RWLK ): Q2 GAAP EPS of -$0.07 misses by $0.03 .
- Revenue of $1.57M (+9.0% Y/Y) misses by $0.75M .
- “Establishing broad access to ambulation technology for the paralyzed community – as well as adding new technologies to improve utilization – is our primary objective,” stated Larry Jasinski, Chief Executive Officer of ReWalk. “Our collaborative efforts with CMS and other bodies on reimbursement, combined with ongoing improvements of the technology, are driving significant progress against this goal. Further, recent public sessions and subsequent interaction with CMS are encouraging steps on this pathway to deliver for patients and create value for our shareholders. We look forward to near-term milestones that have the potential to significantly catalyze our growth via expanded reimbursement.”
For further details see:
ReWalK GAAP EPS of -$0.07 misses by $0.03, revenue of $1.57M misses by $0.75M